Recent Finacing
Recent Raise
Oxford Drug Design operates a cheminformatics and chemistry-informed machine-learning platform to design small-molecule aminoacyl-tRNA synthetase inhibitors, developing oncology and dual-target antibiotic programs and offering platform services to pharma.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
